IDO1 and neoplasm: IDO1 can down-regulate NKG2D and NKG2DL in NK cells by upregulating miR-18a, a microRNA (miRNA) that significantly promotes tumor cell growth, metastasis and inhibit apoptosis in breast cancer, ovarian cancer, lung cancer, and hepatocellular carcinoma [138].